CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune Microenvironment

CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune Microenvironment

The prognosis of patients with endometrial cancer (EC) is closely associated with immune cell infiltration. Although abnormal long non-coding RNA (lncRNA) expression is also linked to poor prognosis in patients with EC, the function and action mechanism of immune infiltration-related lncRNAs underly...

Full description

Bibliographic Details
Main Authors:	Di Yang, Jian Ma, Xiao-Xin Ma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	endometrial cancer lncRNA prognostic signature immune infiltration CDKN2B-AS1
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.721676/full

Similar Items

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
by: Cong Chen, et al.
Published: (2022-06-01)

Identification of a novel cuproptosis-associated lncRNA model that can improve prognosis prediction in uterine corpus endometrial carcinoma
by: Bohan Li, et al.
Published: (2023-12-01)

Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature
by: Hongmei Ding, et al.
Published: (2022-02-01)

Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
by: Yun Chen
Published: (2022-07-01)

Polymorphism rs2383207 of CDKN2B-AS and Susceptibility to Atherosclerosis: A Mini Review
by: Sofia Vladimorovna Timofeeva, et al.
Published: (2022-11-01)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
by: Kaiming Zhang, et al.
Published: (2021-06-01)

A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer
by: Jianmin Zeng, et al.
Published: (2022-11-01)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
by: Xueyuan Huang, et al.
Published: (2023-01-01)

An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma
by: Xin Jiang, et al.
Published: (2023-11-01)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
by: Xiao Yang, et al.
Published: (2022-02-01)

BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer
by: Darmawi, et al.
Published: (2022-06-01)

Identification of m7G-Related LncRNA Signature for Predicting Prognosis and Evaluating Tumor Immune Infiltration in Pancreatic Adenocarcinoma
by: Jiawei Lu, et al.
Published: (2023-05-01)

Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma
by: Liangyin Wu, et al.
Published: (2022-04-01)

Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer
by: Gao C, et al.
Published: (2023-12-01)

N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma
by: Tianming Ma, et al.
Published: (2021-10-01)

Autophagy-Related Genes and Long Noncoding RNAs Signatures as Predictive Biomarkers for Osteosarcoma Survival
by: Jian Zhang, et al.
Published: (2021-08-01)

Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer
by: Wenchang Lv, et al.
Published: (2021-10-01)

Identification of pyroptosis-related genes and long non-coding RNAs signatures in osteosarcoma
by: Jian Zhang, et al.
Published: (2022-10-01)

Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer
by: Leilei Xia, et al.
Published: (2019-05-01)

Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types
by: Yunzhen Wei, et al.
Published: (2020-08-01)

An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
by: Gen Li, et al.
Published: (2022-12-01)

Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma
by: Xiaofeng Cheng, et al.
Published: (2023-01-01)

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
by: Jie Zhao, et al.
Published: (2022-11-01)

Effect of 9p21.3 (lncRNA and CDKN2A/2B) variant on lipid profile
by: Baozhu Wei, et al.
Published: (2022-09-01)

Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
by: Jinzhi Lai, et al.
Published: (2022-03-01)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
by: Yuan Qin, et al.
Published: (2022-09-01)

Machine learning-based disulfidptosis-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity in hepatocellular carcinoma
by: Lei Pu, et al.
Published: (2024-02-01)

COVID-19–associated lncRNAs as predictors of survival in uterine corpus endometrial carcinoma: A prognostic model
by: Yang Ding, et al.
Published: (2022-09-01)

Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
by: Kefan Lin, et al.
Published: (2023-04-01)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
by: Danfeng Li, et al.
Published: (2021-09-01)

Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis
by: Qian Chen, et al.
Published: (2020-10-01)

Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification
by: Chou Yang, et al.
Published: (2022-12-01)

A Cholesterol Homeostasis-Related Gene Signature Predicts Prognosis of Endometrial Cancer and Correlates With Immune Infiltration
by: Yili Chen, et al.
Published: (2021-11-01)

Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression
by: Zhihao Yang, et al.
Published: (2023-03-01)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
by: Liang Huang, et al.
Published: (2022-09-01)

Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer
by: Qiang Tang, et al.
Published: (2022-05-01)

A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer
by: Wei-Peng He, et al.
Published: (2022-11-01)

Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis
by: Dawei Cai, et al.
Published: (2022-08-01)

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
by: Zidan Zhao, et al.
Published: (2023-06-01)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
by: Qian Chen, et al.
Published: (2020-10-01)